Safety | SPINRAZA® (nusinersen) HCP
HSE to consider funding Spinraza as NHS approves muscle-wasting therapy
Biogen announces new data providing further evidence for SPINRAZA (nusinersen) as a treatment for SMA - Spinal News International
Biogen to study higher dose of Spinraza in SMA patients
Novartis' £1.79M gene therapy Zolgensma scores cost watchdog's backing, threatening Biogen's Spinraza | FiercePharma
These highlights do not include all the information needed to use SPINRAZA® safely and effectively. See full prescribing information for SPINRAZA. SPINRAZA (nusinersen) injection, for intrathecal useInitial U.S. Approval: 2016
Spinraza in the UK ‒ questions and answers – TreatSMA
Biogen bounces back with Spinraza early treatment data - PMLiVE
Roche's low-price Evrysdi will take 'meaningful' SMA share from Biogen's Spinraza: analyst | FiercePharma
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
First treatment for 5q spinal muscular atrophy approved by EU
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
Spinraza®: coverage for all SMA type 1,2,3 patients - Institut de Myologie
Spinraza 12 mg solution for injection - Summary of Product Characteristics (SmPC) - (emc)
Biogen's blockbuster rare disease drug could be in trouble
HSE approves Spinraza after lengthy campaign by patients
What is Spinraza? Uses, Side Effects & More | TheSocialMedwork
Official HCP Homepage | SPINRAZA® (nusinersen) | HCP
Spinraza - NPS MedicineWise
Buy Spinraza (Nusinersen) Online • Price & Costs | TheSocialMedwork
Biogen provides information on upcoming Spinraza EU label | SMA Europe
Spinraza - FDA prescribing information, side effects and uses
